AlphaMark Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23,183
| Closed | -$36K | – | 727 |
|
|
2023
Q4 | $36K | Buy |
23,183
+12,635
| +120% | +$19.6K | 0.01% | 373 |
|
|
2023
Q3 | $14K | Hold |
10,548
| – | – | 0.01% | 467 |
|
|
2023
Q2 | $18K | Buy |
10,548
+6,015
| +133% | +$10.3K | 0.01% | 324 |
|
|
2023
Q1 | $7K | Buy |
+4,533
| New | +$7K | ﹤0.01% | 456 |
|
|
2022
Q4 | – | Sell |
-20,000
| Closed | -$29K | – | 618 |
|
|
2022
Q3 | $29K | Hold |
20,000
| – | – | 0.01% | 262 |
|
|
2022
Q2 | $37K | Buy |
20,000
+17,000
| +567% | +$31.5K | 0.02% | 242 |
|
|
2022
Q1 | $8K | Buy |
+3,000
| New | +$8K | ﹤0.01% | 426 |
|
|
2020
Q3 | – | Sell |
-1,390
| Closed | -$12K | – | 536 |
|
|
2020
Q2 | $12K | Hold |
1,390
| – | – | 0.01% | 334 |
|
|
2020
Q1 | $11K | Buy |
1,390
+413
| +42% | +$3.27K | 0.01% | 288 |
|
|
2019
Q4 | $8K | Buy |
977
+440
| +82% | +$3.6K | ﹤0.01% | 355 |
|
|
2019
Q3 | $4K | Buy |
537
+175
| +48% | +$1.3K | ﹤0.01% | 408 |
|
|
2019
Q2 | $4K | Hold |
362
| – | – | ﹤0.01% | 429 |
|
|
2019
Q1 | $4K | Hold |
362
| – | – | ﹤0.01% | 418 |
|
|
2018
Q4 | $5K | Buy |
+362
| New | +$5K | ﹤0.01% | 371 |
|